Australia markets open in 8 hours 11 minutes

BioNTech SE (BNTX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
92.96-1.01 (-1.07%)
As of 09:48AM EST. Market open.
Show:
Annual

Income statement

Currency in EUR. All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
Total revenue
6,618,300
17,310,600
18,976,700
482,300
Cost of revenue
2,319,300
4,532,000
3,860,700
704,300
Gross profit
4,299,000
12,778,600
15,116,000
-222,000
Operating expenses
Research development
-
-
-
2,033
Selling general and administrative
556,300
544,200
336,200
108,500
Total operating expenses
533,400
477,800
197,900
-139,600
Operating income or loss
3,765,600
12,300,800
14,918,100
-82,400
Interest expense
3,900
16,200
5,400
2,000
Total other income/expenses net
-339,500
623,700
154,100
-59,900
Income before tax
3,695,500
12,954,100
15,046,400
-145,800
Income tax expense
944,400
3,519,700
4,753,900
-161,000
Income from continuing operations
2,751,100
9,434,400
10,292,500
15,200
Net income
2,751,100
9,434,400
10,292,500
15,200
Net income available to common shareholders
2,751,100
9,434,400
10,292,500
15,200
Basic EPS
11.27
38.78
42.18
0.06
Diluted EPS
11.27
37.77
39.63
0.06
Basic average shares
241,956
243,300
244,000
253,300
Diluted average shares
241,956
249,800
259,700
253,300